Filgrastim en la enfermedad de Crohn refractaria con absceso intraabdominal / Filgrastim in refractory Crohns disease with an intra-abdominal abscess
Gastroenterol. hepatol. (Ed. impr.)
; 30(4): 232-233, abr.2007.
Article
in Es
| IBECS
| ID: ibc-052541
Responsible library:
ES1.1
Localization: ES1.1 - BNCS
RESUMEN
El tratamiento con factor recombinante estimulante de progenitores granulocíticos (filgrastim) parece ser una alternativa terapéutica segura, bien tolerada y potencialmente efectiva en pacientes con una enfermedad de Crohn activa. Presentamos el caso de un varón adolescente con enfermedad de Crohn y absceso intraabdominal asociado, en el que los tratamientos convencionales habían fracasado, que experimentó una importante respuesta al tratamiento con factor recombinante estimulante de progenitores granulocíticos
ABSTRACT
The aplication of recombinant human granulocyte colony-stimulating factor (filgrastim) seems to be a safe, well tolerated and potentially effective therapy for active Crohn's disease. We report the case of an adolescent boy with Crohn's disease and intra-abdominal abscess associated who had a significant response to treatment with recombinant human granulocyte colony-stimulating factor after all standard treat-ments had failed
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Crohn Disease
/
Abdominal Abscess
/
Filgrastim
Limits:
Adult
/
Humans
/
Male
Language:
Spanish
Journal:
Gastroenterol. hepatol. (Ed. impr.)
Year:
2007
Document type:
Article
Institution/Affiliation country:
Hospital Ramón y Cajal/España